In a new study using variant virus recovered from one of the original travelers, researchers in the US and Japan have found that vaccination with an mRNA vaccine induces antibody responses that would protect humans from infection with the gamma/P.1 variant.
Patients with blood cancers who were hospitalized with COVID-19 fared better if they were given convalescent plasma, according to study findings from a consortium that included the Mays Cancer Center, home to UT Health San Antonio MD Anderson.
A rare parasitic infection imported from Europe continues to take root in Alberta. The province is now the North American hotspot for human alveolar echinococcosis (AE), which takes the form of a growth in the liver, causing serious and potentially deadly health complications.
Nanodecoys made from human lung spheroid cells (LSCs) can bind to and neutralize SARS-CoV-2, promoting viral clearance and reducing lung injury in a macaque model of COVID-19. By mimicking the receptor that the virus binds to rather than targeting the virus itself, nanodecoy therapy could remain effective against emerging variants of the virus.
New in the Hastings Center Report: Racial justice and environmental toxins, gene editing, Covid, and more in the May-June 2021 issue.
Researchers from the MPI of Immunobiology and Epigenetics decipher the basic biology of neutrophil swarming and now show that the cells also evolved an intrinsic molecular program to self-limit their swarming activity. The study elucidates how swarming neutrophils become insensitive to their own secreted signals that brought the swarm together in the first place. This process is crucial for the efficient elimination of bacteria in tissues.
A laboratory at the CDI has discovered a highly sensitive methodology that can efficiently find and harness EVs -- particularly exosomes and the micro RNAs they carry. These could be crucial clues to early identification of diseases like cancer
DNA analysis has revealed the presence of 'Yersinia Pestis' - the pathogen that causes plague - in skeletal remains from individual burials in medieval Cambridgeshire, confirming for the first time that not all plague victims were buried in mass graves. Compassion and care were shown to victims even during traumatic times during past pandemics.
A faster method for collecting pure malaria parasites from infected mosquitos could accelerate the development of new, more potent malaria vaccines.
Researchers from the Hospital del Mar and Pompeu Fabra University have confirmed that messenger RNA vaccines pre-prepared in syringes for their administration can be transported by road for up to three hours. The researchers have conducted stress tests on syringes pre-prepared for administering the Pfizer BioNTech and Moderna vaccines, and have found that the vector these vaccines use, the messenger RNA, maintains its integrity despite being subjected to movement.